# To Determine Tolerability to Glucagon Infusion in Obese Subjects

> **NCT02817659** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AdventHealth Translational Research Institute** · enrollment: 20 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Glucagon

## Key facts

- **NCT ID:** NCT02817659
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-11-01
- **Primary completion:** 2017-01-13
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02817659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02817659, "To Determine Tolerability to Glucagon Infusion in Obese Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02817659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*